Best Drug Manufacturers - Specialty & Generic Stocks in Healthcare for 2026
Top-ranked Drug Manufacturers - Specialty & Generic stocks within the Healthcare sector. Specialty and generic drugmakers compound on volume and niche pricing rather than branded margins, so Valuation leads with Health covering debt service and FDA exposure.
Specialty and Generic Drug Manufacturers earn lower gross margins than big pharma but compound on volume and niche pricing. Composite ranking uses the Valuation pillar as the primary signal (the cohort is structurally cheaper than branded pharma) with Health pillar (debt service, FDA exposure) as the safety floor.
Data as of (updated daily)
Top 20 Drug Manufacturers - Specialty & Generic stocks in Healthcare by composite score
Live results temporarily unavailable. The full screener is at /screener with the Healthcare + Drug Manufacturers - Specialty & Generic filters.
Customise the Healthcare + Drug Manufacturers - Specialty & Generic screen
The full screener applies both filters and lets you stack 30+ more on top: market cap, country, dividend yield, and the four pillar scores.
Open in screener →Explore related pages
Other industries in Healthcare
Browse the hub pages
Methodology: How we score stocks. Data refreshed nightly around 03:30 ET. This page lists the top 20 by composite score within the Drug Manufacturers - Specialty & Generic industry under Healthcare. Use the screener for the full ranked list.